menu
    • menu

    Company profile for Therachon AG

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Therachon is a global biotechnology company focused on developing treatments for serious rare conditions with high unmet medical need. Founded in 2014, Therachon’s first investigational program focused on achondroplasia. Building on our commitment to address the biological roots of serious conditions with high unmet need, we added a product candidate for short bowel syndrome to our portfolio in late 2018. From the start, our...
    Therachon is a global biotechnology company focused on developing treatments for serious rare conditions with high unmet medical need. Founded in 2014, Therachon’s first investigational program focused on achondroplasia. Building on our commitment to address the biological roots of serious conditions with high unmet need, we added a product candidate for short bowel syndrome to our portfolio in late 2018. From the start, our development program has been characterized by well-validated targets, well-characterized patient populations and the potential for our therapies to be best-in-disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Therachon AGSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Aeschenvorstadt 36, 4051 Basel
    Telephone
    Telephone
    +41-798989209
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://therachon.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/therachon
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/therachon?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    VectivBio buys out small Massachusetts biotech, focus on metabolic disease
    VectivBio buys out small Massachusetts biotech, focus on metabolic disease

    31 Aug 2021

    // Max Gelman ENDPTS

    https://endpts.com/luca-santarellis-vectivbio-buys-out-small-massachusetts-biotech-redoubling-focus-on-metabolic-disease/

    Max Gelman ENDPTS
    31 Aug 2021
    Share Share
    Gene therapy player InnoSkel debuts with €20M
    Gene therapy player InnoSkel debuts with €20M

    15 Dec 2020

    // P. Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/gene-therapy-player-innoskel-debuts-eu20m-for-rare-skeletal-diseases

    P. Taylor FIERCE BIOTECH
    15 Dec 2020
    Share Share
    Pfizer Completes Acquisition of Therachon
    Pfizer Completes Acquisition of Therachon

    01 Jul 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/pfizer-completes-acquisition-of-therachon/

    BIOSPACE
    01 Jul 2019
    Share Share
    Therachon to Present Data from Ongoing PhII Study of Apraglutide for (SBS)
    Therachon to Present Data from Ongoing PhII Study of Apraglutide for (SBS)

    17 May 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/therachon-to-present-data-from-ongoing-phase-ii-study-of-apraglutide-for-short-bowel-syndrome-sbs-at-digestive-disease-week-300852157.html

    PR NEWSWIRE
    17 May 2019
    Share Share
    Pfizer expands rare disease pipeline with $820m buyout
    Pfizer expands rare disease pipeline with $820m buyout

    10 May 2019

    // Ben Hargreaves BIOPHARMA-REPORTER

    https://www.biopharma-reporter.com/Article/2019/05/09/Pfizer-acquires-Therachon-for-350m

    Ben Hargreaves BIOPHARMA-REPORTER
    10 May 2019
    Share Share
    Pfizer offers $340M upfront to buy Therachon for dwarfism drug
    Pfizer offers $340M upfront to buy Therachon for dwarfism drug

    09 May 2019

    // Nick P. Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/pfizer-agrees-340m-upfront-to-buy-therachon-for-dwarfism-drug

    Nick P. Taylor FIERCE BIOTECH
    09 May 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search